CyberKnife® radiosurgery effectively addresses the technical limitations of other radiotherapy methods, producing precise ablative radiation coverage of the HCC lesion, and accurately tracking the lesion as it moves with respiration, in a manner whose precision is unequaled by other radiation delivery systems. It may be reasonably be applied as an aggressive “bridge therapy” in a HCC patient awaiting removal of their diseased liver and liver transplantation, either alone or in combination with other therapies, or it may be used as a radiosurgical ablative method with curative intent in selected patients for whom traditional surgery is not an option. Further study of this treatment method in HCC patients is warranted.
Written by Donald B. Fuller, M.D. – Radiation Oncologist